Antimuscarinic 3-(2-Furanyl)quinuclidin-2-ene derivatives: Synthesis and structure-activity relationships

Journal of Medicinal Chemistry

Volumn 40, Issue 23, 1997, Pages 3804-3819

  Johansson, Gary ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 FURANYL)QUINUCLIDIN 2 ENE; 3 [3 (3 HYDROXYPHENYL)FURAN 2 YL]QUINUCLIDIN 2 ENE; MUSCARINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG CONFORMATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GUINEA PIG; MALE; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR AFFINITY;

ANIMALS; BINDING, COMPETITIVE; CEREBRAL CORTEX; GUINEA PIGS; KINETICS; MALE; MOLECULAR CONFORMATION; MUSCARINIC ANTAGONISTS; MUSCLE, SMOOTH; MYOCARDIUM; PAROTID GLAND; QUINUCLIDINES; QUINUCLIDINYL BENZILATE; RADIOLIGAND ASSAY; RECEPTORS, MUSCARINIC; STRUCTURE-ACTIVITY RELATIONSHIP; TRITIUM; URINARY BLADDER;

EID: 0030813612     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970346t     Document Type: Article

References (62)

1. Nilsson, B. M.; Sundquist, S.; Johansson, G.; Nordvall, G.; Glas, G.; Nilvebrant, L.; Hacksell, U. 3-Heteroaryl Substituted Quinuclidin-3-ol and Quinuclidin-2-ene Derivatives as Muscarinic Antagonists.Synthesis and Structure-Activity Relationships. J. Med. Chem. 1995, 38, 473-487.
2. Nordvall, G.; Sundquist, S.; Johansson, G.; Glas, G.; Nilvebrant, L.; Hacksell, U. 3-(2-Benzofuranyl)quinuclidin-2-ene Derivatives: Novel Muscarinic Antagonists.J. Med. Chem. 1996, 39, 3269-3277.
3. See, for example: (a) Sornay, R.; Meunier, J.M.; Fournari, P. N° 166. Synthesis of bromo furans and mono- and disubstituted furan derivatives. Bull. Soc. Chim. Fr. 1971, 990-1000.
4. (b) Carpita, A.; Rossi, R.; Verancini, C. A. Synthesis and 13C NMR Characterization of Some .T-Excessive Heteropolyaromatic Compounds. Tetrahedron 1985, 41, 1919-1929.
5. Gilmah, H.; Burtner, R.R. Orientation in the Furan Nucleus. VI. β-substituted Furans. J. Am. Chem. Soc. 1933, 55, 2903-2909.
6. (a) Chadwick, D. J.; Chambers, J.; Meakins, G.D.; Snowden.R. L. Esters of Furan-, Thiophen-, and AT-Methylpyrrole-2-carboxylic Acids. Bromination of Methyl Furan-2-carboxylate, Furan2-carbaldehyde, and Thiophen-2-carbaldehyde in the presence of Aluminium Chloride. J. Chem. Soc., Perkin Trans, l 1973, 1766-1773.
7. (b) Petfield, R. J.; Amstutz, E. D. Halogen Reactivities. VI. The Reactions of Several a-Bromofurans. The Isolation of 2-Methoxyfuran. J. Org. Chem, 1954,19,1944-1946.
8. Nazarova, Z. N.; Gakh, I.G. Some derivatives of 5-halofurancarboxylic acids. Zh. Obshch. Khim. I960,30, 2322-2326; Chem. Abstr. 1961, 55, 8376f.
9. Williard, J. R.; Hamilton, C.S. Studies in the Furan Series. Chloralfuranamides and Some of Their Reactions. J. Am. Chem. Soc. 1953, 75, 2370-2373.
10. Grigg, R.; Knight, J.A.; Sargent, M. V. Studies in Furan Chemistry. Part I. The Infrared Spectra of 2,5-Disubstituted Furans. J. Chem. Soc. 1965, 6057-6060.
11. Knight, D. W.; Nott, A.P. The Generation and Chemistry of Dianions derived from Furancarboxylic Acids. J. Chem. Soc., Perkin Trans, l 1981, 1125-1131.
12. For examples of using dibromotetrafiuoroethane as electrophile, see: (a) Talham, D.R.; Cowan, D. O. Synthesis of New Biferrocene Derivatives Containig Interannular Bridges and Their Mixed-Valence Analogues. Organometallics 1987, 6, 932-937.
13. (b) Akabori, S.; Habata, Y.; Sato, M.Electron-Transfer Interaction between the Complexed Silverd) Cation and Ruthenium Atom in Polyoxa[n]- and l,n-Dioxathia[n]Ruthenoceophanes. Chem. Lett. 1985, 7, 1063-1066.
14. Finkelstein, B. L. Regioselective Lithiation and Reaction of [l,2,4]Triazolo[l,5-a]pyridine and Pyrazolo[l,5a]pyridine. J. Org. Chem. 1992,57,5538-5540.
15. See, for example: (a) Luthman, K.; Orbe, M.; Wâglund, T.; Claesson, A.Synthesis of C-Glycosides of 3-Deoxy-D-manno-2octulosonic Acid. Stereoselectivity in an Enolate Reaction. J. Org. Chem. 1987,52,3777-3784.
16. (b) Dijkstra, G.; Kruizinga, W. H.; Kellogg, R. M. An Assessment of the Causes of the "Cesium Effect". J. Org. Chem. 1987, 52, 4230-4234.
17. For a review, see: Gschwend, H.W.; Rodriguez, H. R. Heteroatom-Faciliated Lithiations Org. React. 1979, 26, 1-360.
18. Burgess, E. M.; Penton, H.R.; Taylor, E. A. Thermal Reactions of AlkylN-Carbomethoxysulfamate Esters. J. Org. Chem. 1973, 38, 26-31.
19. Dinh Ly, N.; Schlosser, M. 208.A simple synthesis of rose furan and related compounds. Helu. Chim. Acta 1977, 60, 2085-2088.
20. Bock, L; Bornovski, H.; Ranft, A.; Theis, H.New Aspects in the Synthesis of Mono- and Dialkylfurans Tetrahedron 1990, 46, 1199-1210.
21. Zaluski, M. C.; Robba, M.; Bonhomme, M.No 314.-Synthesis of furan dicarbonyl derivatives. II. Preparation by Organolithium Intermediates. Bull. Soc. Chim. Fr. 1970, 1838-1846.
22. Cabri, W.; Candiani, I.; Bedeschi, A.; Penco, S. a-Regioselectivity in Palladium-Catalyzed Arylation of Acyclic Enol Ethers.J. Org. Chem. 1992, 57, 1481-1486.
23. Nordvall, G.; Sundquist, S.; Nilvebrant, L.; Hacksell, U. 3-Lithioquinuclidin-2-ene: A Novel Intermediate for the Synthesis of Muscarinic Agonists and Antagonists.Bioorg. Med. Chem. Lett. 1994, 4, 2837-2840.
24. Malm, J.; Björk, P.; Gronowitz, S.; Hörnfeldt, A.-B.Palladium-Catalyzed Coupling of HeteroarylAlkylstannanes with Heteroarvl Halides in the Presence of Silver(I)oxide. Tetrahedron Lett. 1992, 33, 2199-2202.
25. Gronowitz, S.; Björk, P.; Malm, J.; Hörnfeldt, A.-B.The effect of Some additives on the Stille Pd°-catalyzed cross-coupling reaction. J. Organomet. Chem. 1993, 460, 127-129.
26. Davies, S. G.; Pyatt, D.Synthesis of 1-Substituted Derivatives of Codeine from 1-Bromocodeine via Palladium Catalysed Coupling Reactions. Heterocycles 1989, 28, 163-166.
27. Peters, D.; Hörnfeldt, A.-B.; Gronowitz; S.; Johansson, N.-G.Synthesis of Various 5-Substituted 2'-deoxy-3',5'-di-O-acetyluridines. J. Hetereocycl. Chem. 1991, 28, 529-531.
28. Saunders, J.; Cassidy, M.; Freedman, S.B.; Harley, E. A.; Iversen, L. L.; Kneen, C.; MacLeod, A. M.; Merchant, K. J.; Snow, R. J.; Baker, R. Novel Quinuclidine-Based Ligands for the Muscarinic Cholinergic Receptor. J. Med. Chem. 1990,33,1128-1138.
29. See, for example: Kosugi, M.; Suyima, T.; Obara, Y.; Suzuki, M.; Sano, H.; Migita, T. (a-Ethoxyvinyl)tributyltin; An Efficient Reagent for the Nucleophilic Acetylation of Organic Halides via Palladium Catalysis.Bull. Chem. Soc. Jpn. 1987, 60, 767-768 and references cited therein.
30. For examples of in situ palladium-catalyzed Suzuki reactions, see: (a) Cristofoli, W.A.; Keay, B. A. A Palladium Catalyzed Cross-Coupling Between Furylborates (Generated in situ) and Organohalides. Tetrahedron Lett. 1991, 32, 5881-5884.
31. (b) Maddaford, S. P.; Keay, B. A. Scope and Limitations of the Palladium-Catayzed Cross-Coupling Reactions of in situ Generated Organoboranes with Aryl and Vinyl Halides. J. Org. Chem. 1994, 59, 6501-6503.
32. For examples of the beneficial effect of Cul on the Stille reaction, see: (a) Liebeskind, L.S.; Fengl, R. W. 3-Stannylcyclobutenediones as Nucleophilic Cyclobutenediones Equivalents. Synthesis of Substituted Cyclobutenediones and Cyclobutenedione Monoacetals and the Beneficial Effect of Catalytic Copper Iodide on the Stille Reaction. J.Org. Chem. 1990,55,5359-5364.
33. (b) Farina, V.; Kapadia, S.; Krishnan, B.; Wang, C.; Liebeskind, L. S. On , the Nature of the Copper Effect in the Stille Cross-Coupling. J. Org. Chem. 1994,59, 5905-5911.
34. Johnson, C. R.; Adams, J. P.; Braun, M. P.; Senanayake, C. B. Modified Stille Coupling Utilizing o-Iodoenones. Tetrahedron Lett. 1992, 919-922. (d)Ye, J.; Bhatt, R.; Falck, J. R. Stereospecific Palladium/Copper Cocatalyzed Cross-Coupling of a-Aminostannanes with Acyl Chlorides. J. Am. Chem. Soc. 1994, 116, 1-5. (e) Gibbs, R. A.; Krishnan, U.; Dolence, J. M.; Poulter, C. D. A stereoselective Palladium/Copper-Catalyzed Route to Isoprenoids: Synthesis and Biological Evaluation of 13-Methylidenefarnesyl Diphosphate. J. Org. Chem. 1995, 60, 7821-7829.
35. See, for examples: (a) Hedberg, M.H.; Johansson, A. M.; Nordvall, G.; Yliniemelä, A.; Li, H. B.; Martin, A. R.; Hjorth, S.; Unelius, L.; Sundell, S.; Hacksell, U. (fl)-ll-Hydroxy- and (fl)ll-Hydroxy-10-methylaporphine: Synthesis, Pharmacology, and Modeling of Ü2A and 5-HTu Receptor Interactions. J. Med. Chem. 1995,38,647-658. (b) Cacchi, S.; Cianttini, P. G.; Morera, E.; Ortar, G. Palladium-Catalyzed Triethylammonium Formate Reduction of Aryltriflates. A Selective Method for the Deoxygenation of Phenols. Tetrahedron Lett. 1986, 27, 5541-5544.
36. Grassland, K.; Servis, K.L. A Facile Synthesis of Methanesulfonate Esters. J. Org. Chem. 1970, 35, 3195-3196.
37. Mohamadi, F.; Richards, N.G. J.; Guida, W. C.; Liskamp, R.; Lipton, M.; Caufield, C.; Chang, G.; Hendrickson, T.; Still, W. C. Macromodel - An Integrated Software System for Modeling Organic and Bioorganic Molecules Using Molecular Mechanics. J. Comput. Chem. 1990,11, 440-467.
38. Nilvebrant, L.; Sparf, B.Muscarinic Receptor Binding in the Parotid Gland. Different Affinities of Some Anticholinergic Drugs Between the Parotid Gland and Ileurn. Scand. J. Gastroenterol. 1982, 17 (Suppl. 72), 69-77.
39. Nilvebrant, L.; Sparf, B.Muscarinic Receptor Binding in the Guinea Pig Urinary Bladder. Ada Pharmacol. Toxicol. 1983,52, 30-38.
40. Nilvebrant, L.; Sparf, B.Dicyclomine, Benzhexol and Oxybutynin Distinguish Between Sub-Classes of Muscarinic Binding-sites. Eur. J. Pharmacol. 1986, 123, 133-143.
41. Nilvebrant, L.; Sparf, B.Differences Between Binding Affinities of Some Antimuscarinic Drugs in the Parotid Gland and those in the Urinary Bladder and Ileum. Ada Pharmacol. Toxicol. 1983, 53, 304-313.
42. Wolfe, B. B.; Yasuda, R.P. Development of Selective Antisera for Muscarinic Cholinergic Receptor Subtypes. Ann. N.Y. Acad. Sci. 1995, 151, 186-193.
43. Levey, A. L; Kitt, C.H.; Simmonds, W. F.; Price, D. L.; Brann, M. R. Identification and Localisation of Muscarinic Acetylcholine Receptor Proteins with Subtype-specific Antibodies. J. Neurosci. 1991, ;;, 3218-3226.
44. Peralta, E. G.; Ashkenazi, A.; Winslow, J.W.; Smith, D. H.; Ramachandran, J.; Capon, D. J. Distinct Primary Structure, Ligand-Binding Properties and Tissue-Specific Expression of Four Human Muscarinic Acetylcholine Receptors. EMBO J. 1987, 6, 3923-3929.
45. Dörje, F.; Levey, A.I.; Brann, M. R. Immunological Detection of Muscarinic Receptor Subtype Proteins (ml-m5) in Rabbit Peripheral Tissues. Mol. Pharmacol. 1991, 40, 459-462.
46. Dai, Y.; Ambukar, I.S.; Horn, V. J.; Yeh, C.-K.; Kousvelari, E. E.; Wall, S. E.; Li, M.; Yasuda, R. P.; Wolfe, B. B.; Baum, B. J. Evidence that M3 Muscarinic Receptors in Rat Parotid Gland Couple to Two Second Messenger Systems. Am. J. Physiol. 1991, 261, Cl063-cl073.
47. Wang, P.; Luthin, G.R.; Ruggieri, M. R. Muscarinic Acetylcholine Receptor Subtypes Mediating Urinary Bladder Contractility and Coupling to GTP Binding Proteins. J. Pharmacol. Exp. Ther. 1995, 273, 959-966.
48. Wold, S.; Albano, C.; Dunn, W.J., Ill; Edlund, U.; Esbensen, K.; Geladi, P.; Hellberg, S.; Johansson, E.;. Lindberg, W.; Sjöström, M. In Chemometrlcs-Mathematics and Statistics in Chemistry; Kowalski, B. R., Ed.; Reidel: Dordrecht, 1984; pp 17-95.
49. i(cortex) = 15.200 -0.17572 - 0.82443MR - 0.84142o(para).
50. The PLS equation for the model is pKi(cortex) = 6.3938 -0.17612 - 1.0582MR - 0.77751o(para).
51. In order to explore this possibility, we docked 68 into a homologybased model of the muscarinic ml receptor (see ref 44). During the docking the protonated quinuclidin-2-ene nitrogen was kept interacting via a hydrogen bond reinforced ionic interaction with AsplOS in transmembrane region (TM) 3.The 3-phenyl group could interact with Trpl64. We also identified a possible hydrogen bond interaction with Ser388 in TM6. This is a variable residue between the subtypes (Ser in ml and m5, Asn in m2, m3 and m4). The lack of subtype selectivity exhibited by 68 may be rationalized as both serine and aspargine residues can accept and donate hydrogen bonds to the ligand.
52. Nordvall, G.; Hacksell, U.Binding-site Modelling of the Muscarinic ml Receptor: A Combination of Homology-Based and Indirect Approaches. J. Med. Chem. 1993, 36, 967-976.
53. (a) Gramer, R. D., Ill; Patterson, D.E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967. (b) Cramer, R. D., III; Depriest, S. A.; Patterson, D. E.; Hecht, P. In The Developing Practise of Comparative Molecular Field Analysis. In 3d QSAR in Drug Design: Theory, Methods and Applications; Kubinyi, H., Ed.; ESCOM: Leiden, 1993; pp 443-485. (c) Van Steen, B. J.; Van Wijngaarden, I.; Tulp, M. T.; Soujdin, W. Structure-affinity relationship studies on 5-HTiA receptor ligands. 2. Heterobicyclic phenylpiperazines with N4-aralkyl substituents. J. Med. Chem. 1994, 37, 2761-2773.
54. However, the methyl esters 66 and 67 were not included because they may have been partially hydrolyzed during the binding experiments.
55. Jones, D. H.Phenothiazines: Preparation of 2- and 3-Tertiary Aminophenothiazines. J. Chem. Soc. C 1971, 132-137.
56. See, for example: Bates, R.W.; Gabel, C. J.; Ji, J.; Rama-Devi, T. Synthesis of Phenolic Natural Products Using Palladium Catalyzed Coupling Reactions Tetrahedron 1995,51,8199-8212.
57. Cul was purified by extraction with CH2C12 using a Soxhlet apparatus.
58. Umetri AB, Box 1456, S-901 24 Urnea, Sweden.
59. Wavefunction, Inc., 18401Von Karman Ave., No. 370, Irvine, CA 92715.
60. Lowry, O. H.; Rosebrough, N.J.; Far, A. L.; Randall, R. J. Protein Mesurements with the Folin Phenol Reagent. J. Biol. Chem. 1951, 193, 265-275.
61. Jacobs, S.; Chang, K.-J.; Cuatrecasas, P.Estimation of Hormone Receptor Affinity by Competitive Displacement of Labelled Ligand. Effects of Concentration of Receptor and Labelled Ligand. Biophys. Res. Commun. 1975, 66, 687-692.
62. Schild, H. I. pAx and Competitive Drug Antagonism.Br. J, Pharmacol. Chemother. 1949, 4, 277-280.